Betterchem
Health     Industry Portals     News     For Consumers     21CFR     Search     Site Map

 
LEVETIRACETAM

 
 
Content specific to this active ingredient…

Drug Information
Prescribing and patient information from leading authorities

Drug Master Files
Type 2 master files on file at the FDA

Drug Recalls
For prescription drugs containing this active ingredient

Exclusivity
Patent and market exclusivity data

Federal Register
FR search results for this API

FDA Approved Labelling
Information found in this drug's package inserts

Research Links
Chemical identification and research citations

Title 21 Code of Federal Regulations
FDA regulations for this API

   

 


 

FDA Approval Activities for this Drug…

Keppra (levetiracetam) Solution, UCB Pharma NDA 21-505 7/15/03 7/28/03 Keppra (levetiracetam) Tablets, UCB Pharma, NDA 21-035/S30 9/3/03 9/9/03 Keppra (levetiracetam) Tablets, UCB Pharma, NDA 21-035/S13 & S19 5/22/02 5/29/02 Keppra (levetiracetam) Tablets, 250 mg, 500 mg, and 750 mg. UCB Pharma, NDA 21-035 | Keppra (levetiracetam) Tablets, UCB Pharma, Inc., Labeling Revision | Keppra (levetiracetam) Oral Solution, UCB Pharma, Inc., Labeling Revision | Keppra (levetiracetam) tablets, UCB Pharma, Patient Population Altered | Keppra (levetiracetam) oral solution, UCB Pharma, Patient Population Altered | Keppra (levetiracetam) tablets, UCB, Inc., Formulation Revision | Keppra (levetiracetam) tablets, UCB, Inc., Labeling Revision | Keppra (levetiracetam) oral solution, UCB, Inc., Labeling Revision | Keppra (Levetiracetam) Injection, UCB, Inc., Approval | Keppra (levetiracetam) tablets, UCB, Inc., Labeling Revision | Keppra (levetiracetam) oral solution, UCB, Inc., Labeling Revision | Keppra (levetiracetam) Tablets, UCB Inc., New or Modified Indication | Keppra (levetiracetam) Oral Solution, UCB Inc., New or Modified Indication | Keppra (levetiracetam) Injection, UCB Inc., Labeling Revision | Keppra (levetiracetam) Tablets, UCB Inc., Labeling Revision | Keppra (levetiracetam) Oral Solution, UCB Inc., Labeling Revision | Keppra (levetiracetam) Injection, UCB, Inc., New or Modified Indication | Keppra XR (levetiracetam) Extended-Release Tablets, UCB, Inc., Approval | Levetiracetam Tablets, Mylan Pharmaceuticals Inc., Approval

^ FDA's latest approval appears at the bottom of this list. ^


 

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News

© 2008 Betterchem.com